dimecres, 10 de setembre del 2014

TAVI: Medtronic launches U.S. trial for CoreValve Evolut R




Medtronic follows CE Mark approval of its CoreValve Evolut R transcatheter aortic valve implant with a U.S. clinical trial for the replacement heart valve.








read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1xIRRTR

Cap comentari:

Publica un comentari a l'entrada